Acadian Asset Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Hold |
|
|||||
|
2025
Q1 | $650K | Sell |
|
|||||
|
2024
Q4 | $977K | Sell |
|
|||||
|
2024
Q3 | $1.22M | Sell |
|
|||||
|
2024
Q2 | $1.11M | Buy |
|
|||||
|
2024
Q1 | $1.61M | Buy |
|
|||||
|
2023
Q4 | $1.19M | Buy |
|
|||||
|
2023
Q3 | $988K | Buy |
|
|||||
|
2023
Q2 | $729K | Buy |
|
|||||
|
2023
Q1 | $45K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $700K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $4.33M | Sell |
|
|||||
|
2021
Q3 | $2.96M | Buy |
|
|||||
|
2021
Q2 | $1.83M | Hold |
|
|||||
|
2021
Q1 | $2.01M | Buy |
|
|||||
|
2020
Q4 | $1.71M | Buy |
|
|||||
|
2020
Q3 | $1.41M | Buy |
|
|||||
|
2020
Q2 | $1.13M | Buy |
|
|||||
|
2020
Q1 | $693K | Buy |
|
|||||
|
2019
Q4 | $488K | Buy |
|
|||||
|
2019
Q3 | $174K | Buy |
|
|||||
|
2019
Q2 | $107K | Buy |
|